Boston Scientific Says Cyberattack Likely to Hurt 2026 Sales, Profit

Boston Scientific says it's unlikely to meet 2026 sales and profit forecast after cyberattack

The company said it had made progress restoring affected systems, with major distribution centres now processing and shipping orders

Boston Scientific resumes shipping after cyberattack, but says it's 'unlikely' to hit growth target

Boston Scientific says cyberattack likely to hurt 2026 sales, profit

Boston Scientific Unlikely to Meet Forecasts After Cyber Attack

Boston Scientific Corp. said that fallout from a cybersecurity incident has impacted its ability to ship its products to customers and will cause the medical devices company to miss its sales growth and earnings estimates for the year.

Boston Scientific (BSX) Stock Tumbles as Cyberattack Forces Earnings Warning

Boston Scientific (BSX) shares fell 2.3% after confirming it will miss Q3 and full-year 2026 guidance due to August cyberattack impact on operations.

Boston Scientific (BSX) Stock Falls After Cyberattack Wipes Out Earnings Guidance

TLDR Boston Scientific stock dropped 2.3% in premarket trading after warning it will likely miss its Q3 and full-year 2026 guidance. The guidance warning is directly tied to the cyberattack discovered on August 25. The company previously forecast full-year sales growth of 5.5% to 6.5% and adjusted...